Study Comparing the Bioavailability of TAS-102 Tablets to an Oral Solution Containing Equivalent Amounts of FTD and TPI
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Advanced Solid Tumors (Excluding Breast Cancer)
Interventions: DRUG: TAS-102 tablets|DRUG: TAS-102 oral solution
Sponsor: Taiho Oncology, Inc.